ARCHIVES

R.S.K. Young Quits As FDA Oncology Group Leader

This article is from The Cancer Letter archive.

Vol. 06 No. 28 | July 11, 1980

Download PDF Visit The Full Archive

Related Articles

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985

National Cancer Act Of 1971 Commemorated In Symposium Marking Progress, Future Goals

December 13, 1991

Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge

August 16, 1985

The Cancer Letter To End Print Edition In January

November 20, 2009